BGI-East China covers Jiangsu Province, Zhejiang Province, Fujian Province, Shandong Province and Shanghai, representing the most comprehensively developed region in China on technology, economy, and culture.
BGI Hangzhou, BGI Shanghai and BGI Nanjing were established respectively.
So far, BGI-East China has formed collaborations with more than 70 institutions. Business involves genetic testing for reproductive health, cancer, hereditary diseases disease, pathogenic microorganism detection, and etc.
|BGI Shanghai||BGI Hangzhou||BGI Nanjing|
BGI Shanghai will use genome sequencing and information analysis as core competitiveness, to achieve the application of genomics in medical health, as well as expand the scale of industry in East China.
BGI Hangzhou has achieved a significantly higher visibility in DNA sequence analysis and is developing towards setting up National Bio-industries with independent intellectual property rights.
BGI Nanjing is located in the southwest of Nanjing and serves as the hub for the Yangtze River Delta area and for promoting the development of central and western areas of China. BGI Nanjing diligently strives to promote the transformation of genomic, scientific and technological achievements into applications.
BGI Shanghai was founded on November 11, 2011, in Shanghai century med care park. On December 31, 2012, BGI Shanghai Medical Examination Center was certified the Practicing License of Medical Institution.
BGI Shanghai will apply the competitive sequencing technology and advanced informatics analysis in the fields of medicine and health, and build up a scaled industry.
BGI Hangzhou was founded on January 21, 2001, and set up the largest genome sequencing platform at that time in China with the aim to provide high quality technology service. BGI Hangzhou has participated in a number of internationally advanced genome research, like the International Human Haplotype Map Project (10%), Rice Genome Project, Pig Genome Project.
BGI Hangzhou’s development strategy is to set up a technology platform involves in fundamental research and accelerate applications.
BGI Hangzhou is dedicated to apply genomics research and ttechnological breakthroughs to medical health practices.
BGI Nanjing was founded on September 15, 2011with an area of 2000 square meters. On August 16, 2012 BGI Nanjing Medical Examination Center was certified.
- [news]CFDA Approved Next Generation Sequencing Diagnostic Products
- [news]BGI announces world-leading research centre with the University of Birmingham
- [news]Four BGI Researchers Listed as Thomson Reuters’ Highly Cited
- [news]BGI Ranked 5th of NPI 2013 Top 10 Chinese Institutions
- [news] BGI Listed as Fast Company’s 2014 World’s 50 Most Innovative Companies
- [news]BGI Ranked 119 of Global Top 200 Scientific Institutions in 2012
BGI North China
Address: Building C2-2/3, R& Dcenter, Shiqiaozi Mulan Road, High-tech Zone, Benxi, Liaoning Province, 117004, China
BGI East China
BGI Central China
Address: No. 389 Haiyuan Road, High-tech Development Zone, Kunming, Yunnan, 650106, China
BGI Northwest China
Address(Prepared): Administration Building, No. 6 Xinqiao Road, Yangling District, Xi’an, Shanxi, 712100, China
BGI South China
BGI TibetAddress: No. 189, Jinzhu West Road, Lhasa, 850000, China